WallStSmart

Cresud SACIF y A (CRESY)vsHoneywell International Inc (HON)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cresud SACIF y A generates 2664% more annual revenue ($1.04T vs $37.66B). CRESY leads profitability with a 18.0% profit margin vs 10.9%. CRESY trades at a lower P/E of 6.0x. CRESY earns a higher WallStSmart Score of 55/100 (C-).

CRESY

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 6.0Value: 6.7Quality: 3.5
Piotroski: 3/9Altman Z: 0.83

HON

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 7.5Value: 3.3Quality: 5.5
Piotroski: 4/9Altman Z: 2.05
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CRESY.

HONSignificantly Overvalued (-29.9%)

Margin of Safety

-29.9%

Fair Value

$187.59

Current Price

$241.91

$54.32 premium

UndervaluedFair: $187.59Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRESY2 strengths · Avg: 10.0/10
P/E RatioValuation
6.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.9x10/10

Reasonable price relative to book value

HON3 strengths · Avg: 9.0/10
Return on EquityProfitability
32.6%10/10

Every $100 of equity generates 33 in profit

Market CapQuality
$73.82B9/10

Large-cap with strong market position

Operating MarginProfitability
21.0%8/10

Strong operational efficiency at 21.0%

Areas to Watch

CRESY4 concerns · Avg: 2.8/10
Market CapQuality
$795.78M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.493/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-26.3%2/10

Earnings declined 26.3%

HON4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
2.4%4/10

2.4% revenue growth

Debt/EquityHealth
1.143/10

Elevated debt levels

PEG RatioValuation
8.582/10

Expensive relative to growth rate

EPS GrowthGrowth
-41.9%2/10

Earnings declined 41.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : CRESY

The strongest argument for CRESY centers on P/E Ratio, Price/Book. Profitability is solid with margins at 18.0% and operating margin at 12.2%.

Bull Case : HON

The strongest argument for HON centers on Return on Equity, Market Cap, Operating Margin.

Bear Case : CRESY

The primary concerns for CRESY are Market Cap, Debt/Equity, Piotroski F-Score.

Bear Case : HON

The primary concerns for HON are Revenue Growth, Debt/Equity, PEG Ratio.

Key Dynamics to Monitor

HON carries more volatility with a beta of 0.93 — expect wider price swings.

CRESY is growing revenue faster at 5.0% — sustainability is the question.

HON generates stronger free cash flow (98M), providing more financial flexibility.

Monitor CONGLOMERATES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRESY scores higher overall (55/100 vs 54/100), backed by strong 18.0% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cresud SACIF y A

INDUSTRIALS · CONGLOMERATES · USA

Cresud Sociedad Annima Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, produces agricultural commodities in Brazil and other Latin American countries. The company is headquartered in Buenos Aires, Argentina.

Visit Website →

Honeywell International Inc

INDUSTRIALS · CONGLOMERATES · USA

Honeywell International Inc. is an American publicly traded, multinational conglomerate headquartered in Charlotte, North Carolina. It primarily operates in four areas of business: aerospace, building technologies, performance materials and technologies (PMT), and safety and productivity solutions (SPS).

Want to dig deeper into these stocks?